These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 21130395)

  • 1. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
    Arroua F; Maurin C; Carcenac A; Ragni E; Rossi D; Bastide C
    Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical therapy in metastatic renal cell carcinoma.
    Jonasch E
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
    J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA; Marshall FF; Ogan K
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debulking nephrectomy in metastatic renal cancer.
    Flanigan RC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
    Patard JJ; Pignot G; Escudier B; Eisen T; Bex A; Sternberg C; Rini B; Roigas J; Choueiri T; Bukowski R; Motzer R; Kirkali Z; Mulders P; Bellmunt J
    Eur Urol; 2011 Oct; 60(4):684-90. PubMed ID: 21704448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when.
    Bex A; Powles T
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):787-97. PubMed ID: 22716495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
    Chowdhury S; Harper PG; Choueiri TK
    Nat Clin Pract Oncol; 2008 Dec; 5(12):698-9. PubMed ID: 18852722
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cytoreductive nephrectomy in renal cell carcinoma.
    Chiong E; Wood CG; Margulis V
    Future Oncol; 2009 Aug; 5(6):859-69. PubMed ID: 19663735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma.
    Levy DA; Swanson DA; Slaton JW; Ellerhorst J; Dinney CP
    J Urol; 1998 Apr; 159(4):1168-73. PubMed ID: 9507824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
    Carver BS
    J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastatic renal cell carcinoma: pretherapeutic approach before antiangiogenic treatment. A case report].
    Méjean A; Guy L; Jacqmin D; Joly F; Négrier S; Pignot G
    Prog Urol; 2010 Mar; 20 Suppl 1():S16-9. PubMed ID: 20493437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].
    Oya M; Murai M
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1732-7. PubMed ID: 12402422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for renal cell carcinoma metastases.
    Breau RH; Blute ML
    Curr Opin Urol; 2010 Sep; 20(5):375-81. PubMed ID: 20592612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive nephrectomy: past, present and future.
    Galazi M; Rodriguez-Vida A; Josephides E; Chau NM; Chowdhury S
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):271-7. PubMed ID: 24392671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.